Download DNB 2019 June GASTROENTEROLOGY GASTROENTEROLOGY PAPER 3 Question Paper

Download Diplomate in National Board (DNB) 2019 June GASTROENTEROLOGY GASTROENTEROLOGY PAPER 3 Previous Question Papers

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2019
GASTROENTEROLOGY
PAPER-III
Time: 3 hours GASTRO/J/19/10/III
Max. Marks:100
Important Instructions:
. Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legib/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/f/owcharts wherever appropriate
Write short notes on:
1. a) Newer therapies for Chronic Hepatitis C. 3+3+2+2
b) Treatment of Chronic Hepatitis C in chronic kidney
diseases.
0) Immune escape phenomenon in Hepatitis C infection.
d) Drug resistance in Chronic Hepatitis C.
2. a) POEM Vs Pneumatic Dilatation in Achalasia Cardia. 4+3+3
b) Endoscopic Vs Surgical drainage in Walled off
Necrosis.
c) Endoscopic Vs Surgical treatment of Barrett?s
Esophagus.
3. a) Role of simulators in training and teaching in GI 4+3+3
Endoscopy.
b) Confocal Endoscopy.
c) Narrow Band Imaging.
4. a) Gut microbiota in inflammatory bowel disease (IBD). 3+4+3
b) Fecal microbiota transplant in liver diseases.
c) GLP-1 therapy in IBD.
5. a) Approach to a case of cystic lesions of pancreas. 5+5
b) Role of EUS in diagnosis and treatment of pancreatic
diseases.
6. a) Newer drugs in pipeline for treatment of Chronic 5+5
Hepatitis B.
b) Status of vaccine for Hepatitis E.
7. a) Enteric duplication cysts. 5+5
b) Abdominalcocoon.
P.T.O.
-1.
POSSESSION/USE OF CELL PHONES 0R AN Y S UCH ELECTRONIC GADGETS IS NOTPERMITTED INSIDE THE EXAMINA TION HALL.

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2019
GASTROENTEROLOGY
PAPER-III
8. a) Role of intestinal and epithelial TLR5 in metabolic 4+3+3
syndrome.
b) Genomic profiling in targeted therapy in biliary cancers.
0) Role of proteases in GI diseases.
9. a) Role of EUS in management of biliary tract diseases. 5+5
b) Applications of radiofrequency ablation in GI cancers.
10. a) Hepatic regeneration and its clinical implications. 4+3+3
b) Biological markers for liver fibrosis.
c) Biosimilars in IBD.
************
-2.
POSSESSION/USE OF CELL PHONES 0R AN Y S UCH ELECTRONIC GADGETS IS NOTPERMITTED INSIDE THE EXAMINA TION HALL.